Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritisation.

MLA

King, Charlotte, et al. “Pharmacogenomic Associations of Adverse Drug Reactions in Asthma: Systematic Review and Research Prioritisation.” The Pharmacogenomics Journal, vol. 20, no. 5, Oct. 2020, pp. 621–28. EBSCOhost, https://doi.org/10.1038/s41397-019-0140-y.

APA

King, C., McKenna, A., Farzan, N., Vijverberg, S. J., van der Schee, M. P., Maitland-van der Zee, A. H., Arianto, L., Bisgaard, H., BØnnelykke, K., Berce, V., PotoČnik, U., Repnik, K., Carleton, B., Daley, D., Chew, F. T., Chiang, W. C., Sio, Y. Y., Cloutier, M. M., Den Dekker, H. T., … Hawcutt, D. B. (2020). Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritisation. The Pharmacogenomics Journal, 20(5), 621–628. https://doi.org/10.1038/s41397-019-0140-y

Chicago

King, Charlotte, Amanda McKenna, Niloufar Farzan, Susanne J Vijverberg, Marc P van der Schee, Anke H Maitland-van der Zee, Lambang Arianto, et al. 2020. “Pharmacogenomic Associations of Adverse Drug Reactions in Asthma: Systematic Review and Research Prioritisation.” The Pharmacogenomics Journal 20 (5): 621–28. doi:10.1038/s41397-019-0140-y.